This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Concordia International unit remains under scrutiny for price gouging in UK (*update)

By Aicha Marhfour ( May 31, 2017, 10:31 GMT | Insight) -- Concordia International's UK unit remains under scrutiny in Britain over suspected excessive pricing of drugs, after the country's antitrust authority decided to continue its probe today. Concordia is involved in another UK investigation over alleged excessive pricing of hydrocortisone tablets.This content is from our upcoming UK competition and merger service, devoted to in-depth coverage of the UK as a distinct jurisdiction of increasing importance in the context of Brexit. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections